Stalled confirmatory trials and lax enforcement plague the Food and Drug Administration's accelerated approval pathway for pharmaceuticals that target urgent medical needs.
When Deb Merchant was diagnosed with breast cancer in 2003 she gave her boyfriend a choice: he could "opt out" of their relationship. He had a simple response.
Ecologist Suzanne Simard says trees are "social creatures" that communicate with each other in remarkable ways — including warning each other of danger and sharing nutrients at critical times.
As the rural town of Fort Scott, Kan., grapples with the closure of its hospital, cancer patients bear a heavy burden. They now have to go elsewhere for treatments they used to get locally.
Treatment costs for the immunotherapy can run to more than $1 million. Some state Medicaid programs aren't paying for the treatment, and Medicare's complicated payment rates have hospitals worried.
A nonalcoholic brew joins the growing market to help chemo patients overcome the changes in their palates that make food unappealing. And it just might help them feel better, too.
Thousands of breast cancer patients could now safely avoid chemotherapy thanks to a major study of women with moderate risk of recurrence.
An aggressive type of breast cancer — a HER2-positive tumor — often shrinks with Herceptin treatment, but side effects can be tough. Researchers say a shorter course of the drug may be a good option.
Research finds that more than two-thirds of lung cancer patients who received Keytruda plus chemotherapy would be alive a year later, compared with about half of people who only got chemotherapy.
Side effects from cancer treatment lead many patients to ask their physicians about trying marijuana for relief. Even when the answer is yes, the details on what to do next can be sparse.